Dimensional Fund Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $119M | Buy |
1,585,222
+259,165
| +20% | +$16.6M | 0.02% | 1047 |
|
|
2026
Q1 | $74.7M | Buy |
1,326,057
+233,119
| +21% | +$15.2M | 0.02% | 1271 |
|
|
2025
Q4 | $87.6M | Sell |
1,092,938
-6,581
| -0.6% | -$442K | 0.02% | 1168 |
|
|
2025
Q3 | $53.6M | Buy |
1,099,519
+26,763
| +2% | +$1.66M | 0.01% | 1483 |
|
|
2025
Q2 | $80M | Buy |
1,072,756
+9,054
| +0.9% | +$599K | 0.02% | 1186 |
|
|
2025
Q1 | $67.6M | Buy |
1,063,702
+71,473
| +7% | +$4.86M | 0.02% | 1278 |
|
|
2024
Q4 | $77.5M | Buy |
992,229
+10,990
| +1% | +$883K | 0.02% | 1239 |
|
|
2024
Q3 | $78.9M | Buy |
981,239
+2,504
| +0.3% | +$202K | 0.02% | 1218 |
|
|
2024
Q2 | $81M | Buy |
978,735
+57,665
| +6% | +$5.07M | 0.02% | 1124 |
|
|
2024
Q1 | $78.6M | Buy |
921,070
+94,339
| +11% | +$7.4M | 0.02% | 1140 |
|
|
2023
Q4 | $70.7M | Buy |
826,731
+59,670
| +8% | +$5.16M | 0.02% | 1186 |
|
|
2023
Q3 | $68.7M | Buy |
767,061
+64,402
| +9% | +$5.75M | 0.02% | 1105 |
|
|
2023
Q2 | $59.8M | Buy |
702,659
+1,414
| +0.2% | +$120K | 0.02% | 1226 |
|
|
2023
Q1 | $58M | Buy |
+701,245
| New | +$56.8M | 0.02% | 1212 |
|
|
2022
Q3 | $53.2M | Buy |
718,151
+34,019
| +5% | +$2.44M | 0.02% | 1174 |
|
|
2022
Q2 | $44.6M | Buy |
684,132
+61,035
| +10% | +$3.61M | 0.02% | 1372 |
|
|
2022
Q1 | $39.4M | Buy |
623,097
+69,141
| +12% | +$3.76M | 0.01% | 1584 |
|
|
2021
Q4 | $29.4M | Buy |
553,956
+111,878
| +25% | +$6.82M | 0.01% | 1774 |
|
|
2021
Q3 | $31.2M | Sell |
442,078
-71,171
| -14% | -$4.49M | 0.01% | 1755 |
|
|
2021
Q2 | $34.2M | Buy |
513,249
+9,144
| +2% | +$647K | 0.01% | 1733 |
|
|
2021
Q1 | $56M | Buy |
504,105
+20,002
| +4% | +$2.48M | 0.02% | 1349 |
|
|
2020
Q4 | $57.5M | Buy |
484,103
+17,279
| +4% | +$1.86M | 0.02% | 1257 |
|
|
2020
Q3 | $40.7M | Buy |
466,824
+45,546
| +11% | +$3.98M | 0.02% | 1365 |
|
|
2020
Q2 | $37.7M | Sell |
421,278
-692
| -0.2% | -$69.9K | 0.02% | 1445 |
|
|
2020
Q1 | $42.1M | Sell |
421,970
-8,773
| -2% | -$951K | 0.02% | 1176 |
|
|
2019
Q4 | $49.5M | Sell |
430,743
-46,626
| -10% | -$5.64M | 0.02% | 1448 |
|
|
2019
Q3 | $60.2M | Sell |
477,369
-88,289
| -16% | -$11.2M | 0.02% | 1205 |
|
|
2019
Q2 | $68.1M | Sell |
565,658
-206,968
| -27% | -$20.4M | 0.03% | 1083 |
|
|
2019
Q1 | $67.6M | Sell |
772,626
-245,433
| -24% | -$22.3M | 0.03% | 1057 |
|
|
2018
Q4 | $102M | Sell |
1,018,059
-278,129
| -21% | -$29.2M | 0.05% | 532 |
|
|
2018
Q3 | $149M | Sell |
1,296,188
-144,412
| -10% | -$15M | 0.06% | 403 |
|
|
2018
Q2 | $129M | Sell |
1,440,600
-111,369
| -7% | -$9.4M | 0.05% | 474 |
|
|
2018
Q1 | $114M | Sell |
1,551,969
-49,284
| -3% | -$3.38M | 0.05% | 529 |
|
|
2017
Q4 | $93M | Sell |
1,601,253
-141,028
| -8% | -$7.43M | 0.04% | 684 |
|
|
2017
Q3 | $78.2M | Buy |
1,742,281
+2,547
| +0.1% | +$106K | 0.03% | 781 |
|
|
2017
Q2 | $68.7M | Buy |
1,739,734
+40,381
| +2% | +$1.66M | 0.03% | 864 |
|
|
2017
Q1 | $68.9M | Buy |
1,699,353
+17,963
| +1% | +$702K | 0.03% | 812 |
|
|
2016
Q4 | $67.6M | Sell |
1,681,390
-85,970
| -5% | -$3.24M | 0.03% | 797 |
|
|
2016
Q3 | $64M | Sell |
1,767,360
-37,562
| -2% | -$1.29M | 0.03% | 777 |
|
|
2016
Q2 | $52.3M | Buy |
1,804,922
+228,856
| +15% | +$6.92M | 0.03% | 923 |
|
|
2016
Q1 | $55.1M | Buy |
1,576,066
+126,716
| +9% | +$4.09M | 0.03% | 806 |
|
|
2015
Q4 | $46.7M | Buy |
1,449,350
+52,491
| +4% | +$1.7M | 0.03% | 915 |
|
|
2015
Q3 | $45.1M | Buy |
1,396,859
+109,120
| +8% | +$4.11M | 0.03% | 902 |
|
|
2015
Q2 | $53.3M | Buy |
1,287,739
+137,260
| +12% | +$5.79M | 0.03% | 799 |
|
|
2015
Q1 | $51.7M | Buy |
1,150,479
+212,304
| +23% | +$8.87M | 0.03% | 802 |
|
|
2014
Q4 | $35.1M | Buy |
938,175
+63,240
| +7% | +$2.32M | 0.02% | 1125 |
|
|
2014
Q3 | $30.6M | Buy |
874,935
+113,239
| +15% | +$4.04M | 0.02% | 1144 |
|
|
2014
Q2 | $26.9M | Buy |
761,696
+919
| +0.1% | +$30.7K | 0.02% | 1330 |
|
|
2014
Q1 | $24.8M | Buy |
760,777
+10,092
| +1% | +$386K | 0.02% | 1353 |
|
|
2013
Q4 | $31.6M | Buy |
750,685
+7,379
| +1% | +$304K | 0.02% | 1015 |
|
|
2013
Q3 | $29.6M | Buy |
743,306
+24,385
| +3% | +$1.02M | 0.03% | 968 |
|
|
2013
Q2 | $29.7M | Buy |
+718,921
| New | +$29.1M | 0.03% | 870 |
|
Other funds holding HAE
AI
RRAM
Dimensional Fund Advisors's HAE Position: Q2 2026 in Review
Dimensional Fund Advisors increased its Haemonetics (HAE) stake by 20% in Q2 2026, buying an estimated $16.6M and bringing the position to 1,585,222 shares worth $119M. The position accounts for 0.02% of the portfolio, ranked #1047.
Dimensional Fund Advisors first reported a position in HAE in Q2 2013 and has held it in 52 quarters since. The position peaked at $149M in Q3 2018. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Dimensional Fund Advisors held 1,585,222 shares of Haemonetics worth $119M as of Q2 2026.
- Dimensional Fund Advisors bought 259,165 Haemonetics shares in Q2 2026, an estimated $16.6M.
- Haemonetics made up 0.02% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1047 holding.
- Dimensional Fund Advisors first reported a position in Haemonetics in Q2 2013 and has held it in 52 quarters since.
- Dimensional Fund Advisors's Haemonetics position peaked at $149M in Q3 2018.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.